NCT03133221 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Zydelig given orally at 150 mg twice daily continuously on 28-day cycles starting 30 to 120 days after autologous stem cell transplantation for patients with indolent or transformed indolent B-cell NHL, for up to 1 year maintenance duration. Dose withhold/modification is allowed according to tolerability/toxicity. Zydelig: Zydelig given at 150mg continuously in 28-day cycles
- id
- FG000
- title
- Oral Zydelig 150 mg BID
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 17
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 17
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- Zydelig given orally at 150 mg twice daily continuously on 28-day cycles starting 30 to 120 days after autologous stem cell transplantation for patients with indolent or transformed indolent B-cell NHL, for up to 1 year maintenance duration. Dose withhold/modification is allowed according to tolerability/toxicity. Zydelig: Zydelig given at 150mg continuously in 28-day cycles
- id
- FG000
- title
- Oral Zydelig 150 mg BID
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 17
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 17
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle